Fact CheckerSign in

NCT06519500Recruiting

Generation of Organoids of Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic Tract Obtained From Patients Undergoing Surgery

Source: ClinicalTrials.gov · Last updated 25 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Observational, prospective, feasibility pilot study of the preparation of organoids starting from tumor tissue and surrounding healthy tissue, collected during surgery, performed according to standard clinical practice.

Status (registry)
Recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
19 Jul 2024
Start date
3 Mar 2023
Primary completion date
3 Mar 2026
Lead sponsor
Regina Elena Cancer Institute
NCT number
NCT06519500

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 3 Mar 2023 to the primary completion date, 3 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • previous chemotherapy treatments

Who the study is looking for

  • over 18 years of age;
  • diagnosis of GEP-NEN carried out via histological investigation or via positivity to the uptake PET-CT with 68Ga-peptides;
  • availability of adequate material for the preparation of organoid cultures, derived from surgery;
  • written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Regina Elena National Cancer Institute
Coordinator of this site? Confirm its status
RomeItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.